AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25195125 — intervention group
Group type: COMPARATOR
Intervention: No study drugs
Number of subjects: 200
Study 22227183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D (1,25(OH)₂D)
Number of subjects: 26
Study 22227183 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR
Number of subjects: 26
Study 22227183 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxyvitamin D (1,25(OH)₂D), plasma Ca²⁺, daily physical activity
Number of subjects: 26
Study 19632878 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training in lengthened position
Number of subjects: 45
Study 19632878 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 45
Study 19632878 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 17493295 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief CBT (6-week)
Number of subjects: 72
Study 17493295 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard CBT (12-week)
Number of subjects: 72
Study 15740939 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymectomy through manubriotomy
Number of subjects: 50
Study 15740939 — intervention group
Group type: COMPARATOR
Intervention: Thymectomy through median sternotomy
Number of subjects: 50
Study 12045763 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionator appliance
Number of subjects: 66
Study 12045763 — intervention group
Group type: EXPERIMENTAL
Intervention: FR-2 appliance
Number of subjects: 66
Study 12045763 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 66
Study 10433584 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal conjugate vaccine
Number of subjects: 112
Study 10433584 — intervention group
Group type: COMPARATOR
Intervention: Pneumococcal polysaccharide vaccine
Number of subjects: 112
Study 7731378 — intervention group
Group type: EXPERIMENTAL
Intervention: Climen (2 mg estradiol valerate and 1 mg cyproterone acetate)
Number of subjects: 38
Study 7731378 — intervention group
Group type: COMPARATOR
Intervention: Prempak-C (0.625 mg conjugated equine estrogens and 0.15 mg norgestrel)
Number of subjects: 38
Study 7731378 — intervention group
Group type: EXPERIMENTAL
Intervention: Climen
Number of subjects: 38
Study 7731378 — intervention group
Group type: COMPARATOR
Intervention: Prempak-C
Number of subjects: 38
Study 1696662 — intervention group
Group type: EXPERIMENTAL
Intervention: verapamil 160 mg b.i.d.
Number of subjects: 10
Study 1696662 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 50 mg b.i.d.
Number of subjects: 10
Study 1696662 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 7438948 — intervention group
Group type: EXPERIMENTAL
Intervention: Urecholine
Number of subjects: 263
Study 7438948 — intervention group
Group type: EXPERIMENTAL
Intervention: Dibenzyline (10 mg doses orally, four and eight hours after surgery)
Number of subjects: 263
Study 7438948 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 263
Study 30779128 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher serum thioproline and thioproline combined with cystine and cysteine
Number of subjects: 523
Study 30779128 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipeptide leucylglycine
Number of subjects: 523
Study 30779128 — intervention group
Group type: EXPERIMENTAL
Intervention: Three gamma‐glutamyl amino acids
Number of subjects: 523
Study 30779128 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone body 3‐hydroxybutyrate (BHBA), acyl carnitines, and dicarboxylic fatty acids
Number of subjects: 523
Study 28243722 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 × 0.5 Gy (experimental group)
Number of subjects: 127
Study 28243722 — intervention group
Group type: COMPARATOR
Intervention: 6 × 1 Gy (standard group)
Number of subjects: 127
Study 28243722 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-irradiation with standard dose
Number of subjects: 127
Study 25339642 — intervention group
Group type: COMPARATOR
Intervention: Leaflet and advice (Control)
Number of subjects: 0
Study 25339642 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection
Number of subjects: 0
Study 25339642 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand exercises
Number of subjects: 0
Study 25339642 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint protection plus hand exercises
Number of subjects: 0
Study 24321380 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Positive Pressure Breathing (IPPB)
Number of subjects: 45
Study 24321380 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary Positive Expiratory Pressure (TPEP)
Number of subjects: 45
Study 24321380 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological therapy alone (Control group)
Number of subjects: 45
Study 21942813 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-rich bread (3-4 slices daily for 6 weeks)
Number of subjects: 33
Study 21942813 — intervention group
Group type: COMPARATOR
Intervention: Control bread (3-4 slices daily for 6 weeks)
Number of subjects: 33
Study 21942813 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Iron-rich and Control)
Number of subjects: 33
Study 19542983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300-450 mg/day
Number of subjects: 1002
Study 19542983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 1002
Study 19542983 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/day
Number of subjects: 1002
Study 19542983 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepines (alprazolam or lorazepam)
Number of subjects: 1002
Study 19542983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1002
Study 17479606 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 67
Study 17479606 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide plus inhaled formoterol fumarate
Number of subjects: 67
Study 17479606 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide and oral montelukast sodium therapy
Number of subjects: 67
Study 17479606 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 67
Study 15727375 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg triamcinolone intra‐articular injection
Number of subjects: 26
Study 15727375 — intervention group
Group type: COMPARATOR
Intervention: triamcinolone oral tablets
Number of subjects: 26
Study 11756910 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 50
Study 11756910 — intervention group
Group type: COMPARATOR
Intervention: Inhalational anesthesia (Control)
Number of subjects: 50
Study 9691504 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention designed to increase hope
Number of subjects: 96
Study 9691504 — intervention group
Group type: COMPARATOR
Intervention: Attention control group participating in the 'Learning to Live with Cancer' program
Number of subjects: 96
Study 9691504 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 1362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol administered as a 120 h infusion at 36 mg/m2/d
Number of subjects: 20
Study 1362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol administered as a 120 h infusion at 30 mg/m2/d
Number of subjects: 20
Study 1362568 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxol administered as a 120 h infusion
Number of subjects: 20
Study 3815713 — intervention group
Group type: EXPERIMENTAL
Intervention: WAT40
Number of subjects: 24
Study 3815713 — intervention group
Group type: COMPARATOR
Intervention: RSS
Number of subjects: 24
Study 3815713 — intervention group
Group type: COMPARATOR
Intervention: SAS40
Number of subjects: 24
Study 3815713 — intervention group
Group type: COMPARATOR
Intervention: SAS40 vs RSS
Number of subjects: 24
Study 30150328 — intervention group
Group type: EXPERIMENTAL
Intervention: REMOTE‐CR (telerehabilitation)
Number of subjects: 162
Study 30150328 — intervention group
Group type: COMPARATOR
Intervention: CBexCR (centre-based rehabilitation)
Number of subjects: 162
Study 29704940 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide treatment
Number of subjects: 48
Study 29704940 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 48
Study 27310494 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher health literacy
Number of subjects: 198
Study 27310494 — intervention group
Group type: EXPERIMENTAL
Intervention: Caucasian participants (n = 63)
Number of subjects: 198
Study 27310494 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusting for health literacy
Number of subjects: 198
Study 24722044 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief educational intervention (tailored written stroke information, verbal reinforcement of information for 3 months after discharge, and provision of a telephone number)
Number of subjects: 66
Study 24722044 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 66
Study 23177103 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous sac embolization (VSE)
Number of subjects: 21
Study 23177103 — intervention group
Group type: COMPARATOR
Intervention: Transcatheter feeding artery embolization (FAE)
Number of subjects: 21
Study 20703160 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-step strategy
Number of subjects: 12
Study 20703160 — intervention group
Group type: COMPARATOR
Intervention: Single-step strategy
Number of subjects: 12
Study 17931928 — intervention group
Group type: COMPARATOR
Intervention: Hand/rotary technique
Number of subjects: 31
Study 17931928 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand/rotary/ultrasound technique
Number of subjects: 31
Study 16028649 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment (0.25 mg/kg on days 1-7, 0.12 mg/kg on days 8-14, 0.05 mg/kg on days 15-21, 0.02 mg/kg on days 21-28)
Number of subjects: 116
Study 16028649 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dexamethasone treatment)
Number of subjects: 116
Study 16028649 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone treatment
Number of subjects: 116
Study 16028649 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 116
Study 11996616 — intervention group
Group type: EXPERIMENTAL
Intervention: Education every 2 weeks while in jail
Number of subjects: 558
Study 11996616 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive for visiting the tuberculosis clinic within 1 month of release
Number of subjects: 558
Study 11996616 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 558
Study 11996616 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 558
Study 11996616 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive group
Number of subjects: 558
Study 11996616 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 558
Study 11996616 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group (among those who went to the tuberculosis clinic)
Number of subjects: 558
Study 9788977 — intervention group
Group type: EXPERIMENTAL
Intervention: Human parathyroid hormone 1-34 (hPTH 1-34)
Number of subjects: 0
Study 9788977 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-only group (Control)
Number of subjects: 0
Study 9788977 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers of bone formation during the first 3 months of PTH treatment
Number of subjects: 0
Study 9788977 — intervention group
Group type: EXPERIMENTAL
Intervention: Markers of bone resorption during the first 3 months of PTH treatment
Number of subjects: 0
Study 7587796 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (12 mg chewing gum)
Number of subjects: 11
Study 7587796 — intervention group
Group type: COMPARATOR
Intervention: Placebo chewing gum
Number of subjects: 11
Study 7587796 — intervention group
Group type: COMPARATOR
Intervention: Control period (no chewing gum)
Number of subjects: 11
Study 2262701 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 0
Study 2262701 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 0
Study 2262701 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide and ranitidine
Number of subjects: 0
Study 7377659 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (30 mg/kg IV, repeated doses every six hours)
Number of subjects: 95
Study 7377659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 7377659 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 95
Study 31049835 — intervention group
Group type: EXPERIMENTAL
Intervention: High temperature treatment (30–40 °C) for 15 days
Number of subjects: 60
Study 31049835 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 °C)
Number of subjects: 60
Study 27133000 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-of-care therapy with video models
Number of subjects: 28
Study 27133000 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care therapy without videos
Number of subjects: 28
Study 25412614 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1152
Study 25412614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1152
Study 25412614 — intervention group
Group type: COMPARATOR
Intervention: Medical Treatment Only (MTO)
Number of subjects: 1152
Study 23314179 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 30
Study 23314179 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 30
Study 23314179 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarter prone position
Number of subjects: 30
Study 23314179 — intervention group
Group type: COMPARATOR
Intervention: Spontaneously breathing infants
Number of subjects: 30
Study 23314179 — intervention group
Group type: COMPARATOR
Intervention: Ventilated infants
Number of subjects: 30
Study 20869206 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaghetti with 10% Barley Balance (BB)
Number of subjects: 9
Study 20869206 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaghetti with Glucagel (GG)
Number of subjects: 9
Study 20869206 — intervention group
Group type: EXPERIMENTAL
Intervention: Spaghetti with increasing concentrations of Barley Balance (BB)
Number of subjects: 9
Study 20869206 — intervention group
Group type: COMPARATOR
Intervention: Control (spaghetti without β-glucan)
Number of subjects: 9
Study 20869206 — intervention group
Group type: COMPARATOR
Intervention: Control (glucose reference food)
Number of subjects: 9
Study 19938897 — intervention group
Group type: EXPERIMENTAL
Intervention: Fampridine-SR (10 mg twice daily)
Number of subjects: 100
Study 19938897 — intervention group
Group type: EXPERIMENTAL
Intervention: Fampridine-SR (30 mg twice daily)
Number of subjects: 100
Study 19938897 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin (400 mg on treatment day 5)
Number of subjects: 100
Study 19938897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 17122715 — intervention group
Group type: EXPERIMENTAL
Intervention: General antidepressant requests
Number of subjects: 152
Study 17122715 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand-specific antidepressant requests
Number of subjects: 152
Study 17122715 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication requests
Number of subjects: 152
Study 17122715 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression history taking
Number of subjects: 152
Study 15301041 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (TU) 40 mg daily
Number of subjects: 14
Study 15301041 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular depot sustanon 50 (SUS), 4 weekly
Number of subjects: 14
Study 15301041 — intervention group
Group type: COMPARATOR
Intervention: Run-in and wash-out periods
Number of subjects: 14
Study 11716062 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed condition (participants were told the task required inference from premise pairs)
Number of subjects: 0
Study 11716062 — intervention group
Group type: COMPARATOR
Intervention: Uninformed condition (participants were told to learn pairs by trial and error)
Number of subjects: 0
Study 9444731 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (students)
Number of subjects: 196
Study 9444731 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (mothers)
Number of subjects: 196
Study 9444731 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated hotline calls (students and mothers)
Number of subjects: 196
Study 7862838 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg triazolam
Number of subjects: 2
Study 7862838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 2643606 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) for meniscal lesions
Number of subjects: 50
Study 2643606 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI) for anterior cruciate ligament (ACL) tears
Number of subjects: 50
Study 5036880 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagotomy
Number of subjects: 33
Study 5036880 — intervention group
Group type: COMPARATOR
Intervention: Control (pre-vagotomy)
Number of subjects: 33
Study 30919407 — intervention group
Group type: EXPERIMENTAL
Intervention: ASN002 20 mg
Number of subjects: 36
Study 30919407 — intervention group
Group type: EXPERIMENTAL
Intervention: ASN002 40 mg
Number of subjects: 36
Study 30919407 — intervention group
Group type: EXPERIMENTAL
Intervention: ASN002 80 mg
Number of subjects: 36
Study 30919407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29175810 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based nutrition education intervention
Number of subjects: 900
Study 29175810 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 900
Study 25305090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)/90 mg twice-daily maintenance dose (MD)
Number of subjects: 40
Study 25305090 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 600 mg LD/75 mg once-daily MD
Number of subjects: 40
Study 25305090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 40
Study 25305090 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 40
Study 23870441 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Check-Up (FCU) intervention
Number of subjects: 593
Study 23870441 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 593
Study 20683244 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate-mefloquine
Number of subjects: 109
Study 20683244 — intervention group
Group type: COMPARATOR
Intervention: mefloquine
Number of subjects: 109
Study 20683244 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine
Number of subjects: 109
Study 20683244 — intervention group
Group type: COMPARATOR
Intervention: amodiaquine-artesunate
Number of subjects: 109
Study 19344028 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable membrane (Bio-Gide) applied over the grafted sinus
Number of subjects: 6
Study 19344028 — intervention group
Group type: COMPARATOR
Intervention: Control side (uncovered graft)
Number of subjects: 6
Study 19344028 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable membrane (Bio-Gide)
Number of subjects: 6
Study 17143302 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH 500 microg/day
Number of subjects: 0
Study 17143302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15163693 — intervention group
Group type: EXPERIMENTAL
Intervention: Williams syndrome (WS) group
Number of subjects: 43
Study 15163693 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study 11339453 — intervention group
Group type: EXPERIMENTAL
Intervention: SMAR(X)T
Number of subjects: 80
Study 11339453 — intervention group
Group type: COMPARATOR
Intervention: Standard PVC control
Number of subjects: 80
Study 9389293 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 10 microg
Number of subjects: 10
Study 9389293 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin 100 microg
Number of subjects: 10
Study 8193441 — intervention group
Group type: EXPERIMENTAL
Intervention: McGill Pain Questionnaire
Number of subjects: 54
Study 8193441 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief pain diary
Number of subjects: 54
Study 8193441 — intervention group
Group type: COMPARATOR
Intervention: Checklist of foods consumed (Control)
Number of subjects: 54
Study 3630890 — intervention group
Group type: EXPERIMENTAL
Intervention: Type A behavioral counseling (4.5 years followed by 1 year of no counseling)
Number of subjects: 289
Study 3630890 — intervention group
Group type: COMPARATOR
Intervention: Type A behavioral counseling (1 year)
Number of subjects: 289
Study 29954374 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tocotrienol (430 mg tocotrienol/day from DeltaGold 70 containing 300 mg tocotrienol)
Number of subjects: 89
Study 29954374 — intervention group
Group type: EXPERIMENTAL
Intervention: High tocotrienol (860 mg tocotrienol/day from DeltaGold 70 containing 600 mg tocotrienol)
Number of subjects: 89
Study 29954374 — intervention group
Group type: COMPARATOR
Intervention: Placebo (430 mg olive oil/day)
Number of subjects: 89
Study 27363723 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-releasing implant
Number of subjects: 80
Study 25917008 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 87
Study 25917008 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure Therapy (ET)
Number of subjects: 87
Study 24351999 — intervention group
Group type: EXPERIMENTAL
Intervention: PLISSIT model sexual health enhancement program (4 sessions, 90 minutes each)
Number of subjects: 43
Study 24351999 — intervention group
Group type: COMPARATOR
Intervention: Control group (received intervention post-experiment)
Number of subjects: 43
Study 24351999 — intervention group
Group type: EXPERIMENTAL
Intervention: PLISSIT model sexual health enhancement program
Number of subjects: 43
Study 22147094 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (L-T4)
Number of subjects: 33